According to Jam Press, a TikToker ( @‌onenevertwhoo_one) who preferred to only be referred to by his social media name, ...

Barely a year after the U.S. FDA shackled Abeona Therapeutics Inc.’s cell-based gene therapy with a complete response letter, the agency has approved it for treating a rare and genetic skin disease.

Imagine a creature that looks like a mashup from a child’s wildest dreams: a furry animal with the bill of a duck, the tail ...

Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal ...

Medically reviewed by Casey Gallagher, MD Atopic dermatitis (AD) is a chronic (long-term) skin condition that causes itchy, ...